Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation

Background Rifampicin-resistant tuberculosis (RR-TB) treatment requires combination treatment, which frequently causes serious adverse events and globally results in not much more than 60% treatment success. In Niger, a high cure rate was obtained with a RR-TB treatment strategy based on a second-li...

Full description

Saved in:

Bibliographic Details
Published in:	Current controlled trials in cardiovascular medicine Vol. 23; no. 1; pp. 1011 - 14
Main Authors:	Souleymane, Mahamadou Bassirou, Decroo, Tom, Soumana, Alphazazi, Maman Lawan, Ibrahim, Gagara-Issoufou, Assiatou, Halidou-Moussa, Souleymane, Ortuño-Gutiérrez, Nimer, Adehossi, Eric, Mamadou, Saïdou, Van Deun, Armand, Piubello, Alberto
Format:	Journal Article
Language:	English
Published:	London BioMed Central 13.12.2022 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	All oral treatment Antitubercular agents Antitubercular Agents - adverse effects Audiometry Biomedicine Care and treatment Clinical trials Contraindications Corporate sponsorship Diagnosis Dosage and administration Drugs Evaluation Health Sciences Hearing loss Humans Informed consent Laboratories Linezolid - adverse effects Medicine Medicine & Public Health New anti-tuberculosis drugs Niger Patient compliance Patient outcomes Patients Randomized Controlled Trials as Topic Rifampicin resistance tuberculosis Rifampin - adverse effects Statistics for Life Sciences Study Protocol Success Testing Tuberculosis Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Pulmonary - diagnosis Niger New anti-tuberculosis drugs All oral treatment Niger Rifampicin resistance tuberculosis
ISSN:	1745-6215, 1745-6215
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!